期刊文献+

特发性炎症性肌病的心血管表现 被引量:2

Cardiac Involvement in Idiopathic Inflammatory Myopathies
下载PDF
导出
摘要 心脏损害是特发性炎症性肌病死亡和致残的重要原因。然而,心力衰竭、传导异常及冠心病等临床心血管表现相对少见,非特异性的心电图显示的传导异常及心律失常却很常见。事实上,这些心血管表现或多或少与心肌纤维化及小血管平滑肌增生相关,可致特发性炎症性肌病患者的死亡。因此,有必要推荐特发性炎症性肌病患者进行常规而全面的心脏评估。 Cardiac involvement is an important cause of morbidity and mortality in patients with idiopathic inflammatory myopathies. Despite this, clinically manifest cardiac involvement in polymyositis and dermatomyositis, such as congestive heart failure, conduction abnormalities and coronary artery disease, is relatively rare, and subclinical manifestations are frequently reported and are predominated by conduction abnormalities and arrhythmias detected by ECG. Here, myocardial fibrosis puts the patient at risk for systolic or diastolic heart failure and dysrhythmias, which may constitute a major cause of death in myositis. Therefore, it is reasonable to suggest that these patients should be routinely and comprehensively evaluated for cardiac involvement.
出处 《心血管病学进展》 CAS 2012年第1期122-125,共4页 Advances in Cardiovascular Diseases
关键词 皮肌炎 多发性肌炎 特发性炎症性肌病 心力衰竭 心肌炎 dermatomyositis polymyositis idiopathic inflammatory myopathy heart failure myocarditis
  • 相关文献

参考文献35

  • 1Bohan A, Peter JB. Polymyositis and dermatomyositis [ J ]. N Engl J Med, 1975, 292 : 344-347.
  • 2Dalakas MC, Hohlfeld R. Polymyositis and dcrmatomyositis [ J]. Lancet, 2003, 362: 971-982.
  • 3Dalakas MC. Polymyositis, dermatemyositis and inclusion-body myositis [J]. N Engl J Med, 1991, 325 : 1487-1498.
  • 4Oppenheim H. Zur dermatomyositis [ J]. Berl Klin Wochenschrift, 1899, 36: 805 -807.
  • 5Askari AD. The heart in polymyositis and dermatomyositis [ J ]. Mt Sinai J Med, 1988, 55:479-482.
  • 6Danko K, Ponyi A, Constantin T, et al. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases [ J]. Medicine. 2004,83,35-42.
  • 7Suhan SM, Ioannou Y, Moss K, et al. Outcome in patients with idiopathic inflammatory myositis : morbidity and mortality [ J ]. Rheumatology, 2002, 41 : 22-26.
  • 8DeWere R, Bradley WG. Polymyositis : its presentation, morbidity and mortality [J]. Brain, 1975, 98:637-666.
  • 9Gupta R, Wayangankar SA, Targoff IN, el al. Clinical cardiac involvement in idiopathic im'lammatory myopathies: a systematic review [ J ]. Int J Cardiol, 2011, 148:261-270.
  • 10Gonzalez LL, Gamez-Nava JI, Sanehez L. Cardiac manifestations in derma topolymyositis [J]. Clin Exp Rheumatol, 1996, 14:373-379.

二级参考文献16

  • 1Bohan A,Peter JB.Polymyositis and dermatomyositis[J].J New Eng Med,1975,292:344.
  • 2Bradnal P,Pospisil M,Vizd'a J,et al.A 5-year study of cardiac involvement in polymyositis/dermatomyositis[J].Vnitr Lek,1990,36:1066.
  • 3Gonzale-Lopez L,Gamez-Nava JI,Sanchez L.Cardiac manifestations in dermato-polymyositis[J].Clin Exp Rheumatol,1996,14:373.
  • 4Marie I,Hachulla E,Cherin P,et al.Interstitial lung disease in polymyositis and dermatomyositis[J].Arthritis Rheumatism,2002,47:614.
  • 5Bohan A, Peter JB. Polymyositis and dermatomyositis. New Engl J Med, 1975, 292: 344-348.
  • 6Hastillo A, Willis HS, Hess ML, et al. The heart as a target organ of immune injury.Curr Probl Cardiol,1991,6:406.
  • 7Rchavia E, Rotenberg Z, Fuchs J, et al. Polymyositic heart disease. Chest, 1985, 88: 309-310.
  • 8Tami LF, Bhasin S. Polymorphism of the cardiac manifestation in9 dermatomyositis. Clin Cardiol, 1993, 16: 260-264.
  • 9Pereira RM, Lerner S, Maeda WT, et al. Pericardial tamponade in juvenile dermatomyositis. Clin Cardiol, 1992, 15: 301-303.
  • 10Kehoe RF, Bauemfeid R, Tommaso C, et al. Cardiac conduction defects in polymyositis. Ann Inter Med, 1981, 94: 41-43.

共引文献18

同被引文献26

  • 1Wang H, Liu HX, Wang YL, et al. Left ventricular diastolic dysfunction in patients with dermatomyositis without clinically evident cardiovascular disease [ J]. J Rheumatol, 2014, 41:495-500.
  • 2Gupta R, Wayangankar SA, Targoff IN, et al. Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review [J]. Int J Cardiol, 2011, 148: 261-270.
  • 3Sugiura T, Kumon Y, Kataoka H, et al. Asymptomatic pericardia1 effusion in patients with rheumatoid arthritis [J]. Cardiology, 2008, 110:87-91.
  • 4Sugiura T, Kumon Y, Kataoka I-I, et al. Asymptomatic pericardial effusion in patients with systemic lupus erythematosus [J]. Lupus, 2009, 18:128-132.
  • 5Kitchongcharoenying P, Foocharoen C, Mahakkanukrauh A, et al. Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients [ J ]. Asian Pac J Allergy Immunol, 2013, 31:314-319.
  • 6Bohan A, Peter JB. Polymyositis and dermatomyositis [J]. N Engl J Med, 1975, 292:44-47.
  • 7Suzuki F, Kubota T, Miyazaki Y, et al. Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity [J]. Arthritis Res Ther, 2012, 14 : R48.
  • 8Meyer O. Atherosclerosis and connective tissue diseases [J]. Joint Bone Spine, 2001, 68:564-575.
  • 9Bartoloni Bocci E, Luccioli F, Angrisani C, et al. Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases [ J].Expert Rev Clin Immunol, 2007, 3:531-541.
  • 10Lai YT, Dai YS, Yen MF, et al. Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovaseular events: a Taiwan Residents population-based longitudinal follow-up study [J]. Br J Dermatol, 2013, 168:1054-1059.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部